Identification of chronic myeloid leukemia patients treated with imatinib who are potentially eligible for treatment discontinuation by assessing real-life molecular responses on the international scale in a EUTOS-certified lab
Keywords: مقیاس بین المللی; CML; chronic myeloid leukemia; CML-CP; chronic myeloid leukemia in chronic phase; DMR; deep molecular response; ELN; European LeukemiaNet; ENESTFreedom; Evaluating Nilotinib Efficacy and Safety in Clinical Trials - Following REsponsE in De nOvo CML-CP P